23andMe’s Genetic Test for How You’ll React to Medication Is Ahead of Its Time

November 5, 2018

(The Verge) – On Wednesday, the US Food and Drug Administration approved the first consumer DNA test that promises to tell buyers which drugs might work best for them according to their genetic profile. The manufacturer, 23andMe, won FDA approval by being very careful not to overpromise what its test can do— so careful that the approval highlights the limited usefulness of the test and how much we still don’t know about this field of medicine.

Recommended Reading